LOS ANGELES, Nov 17 (Reuters) - Quest Diagnostics Inc's molecular test for identifying patients infected with the H1N1 flu virus has been approved by European regulators and is available for ...

"Quest's AD-Detect suite of advanced diagnostics has grown to include a range of validated blood-based biomarkers, giving providers options for personalizing testing for the individual patient," said ...

Quest to develop laboratory tests and support public health reporting and laboratory readiness for CDC's preparedness strategy; Company to introduce clinical testing for avian flu later this month ...

In an oral presentation at the 2025 AAN Annual Meeting, Quest scientists presented data suggesting the test can accurately assess Alzheimer's disease pathology with greater than 90% sensitivity and ...

SECAUCUS, N.J., July 15, 2025 /PRNewswire/ -- Quest Diagnostics (DGX), a leader in diagnostic information services, today announced the launch of a new diagnostic laboratory test for the Oropouche ...

While Quest Diagnostics introduced a new Alzheimer’s blood test in July, Alzheimer’s experts are not convinced the test is backed by sound scientific research. TNS For the first time, people worried ...

First consumer genetic health test under the Quest brand provides insights based on DNA, with unique features that include next-generation sequencing, robust support services, physician ordering, and ...